Zhongguo quanke yixue (Jan 2024)

Epidemic Status, Disease Burden and Prediction of Cardiovascular Diseases in China, 1990-2019

  • YANG Ji, ZHANG Yao, MA Teng, TIAN Xintong, ZHAO Yingqiang

DOI
https://doi.org/10.12114/j.issn.1007-9572.2023.0470
Journal volume & issue
Vol. 27, no. 02
pp. 233 – 244

Abstract

Read online

Background Cardiovascular disease is a major chronic disease that seriously endangers human health, and remains a public health problem to be solved in China and even globally. Objective To explore the epidemic characteristics and disease burden of cardiovascular diseases in China from 1990 to 2019, forecast the incidence of cardiovascular diseases in China from 2020 to 2050, and provide a reference for the formulation of relevant prevention and treatment strategies of cardiovascular diseases. Methods The 2019 Global Burden of Disease Study (GBD 2019) database was searched to extract and analyze relevant data on cardiovascular disease burden and risk factors in China and globally from 1990 to 2019. The prevalence of cardiovascular diseases was quantified by using the publicly available incidence, prevalence, mortality, and corresponding age-standardized rate (referred to as standardized rate) based on GBD 2019 database, and the burden of diseases was quantified by years lived with disability (YLD), years of life lost (YLL) and disability adjusted life year (DALY), and the ARIMA model was constructed to predict the incidence of cardiovascular diseases in China from 2020 to 2050. Results Compared with 1990, the incidence, prevalence and mortality of cardiovascular diseases in China showed an increasing trend by year up to 2019, in which the incidence, prevalence and mortality increased by 93.75%, 99.75% and 57.39%, respectively. The standardized incidence and prevalence of females were higher than those of males, while the standardized mortality was lower than that of males (P<0.05). According to the data in 2019, the overall incidence of cardiovascular diseases in China showed an increasing trend with age, reaching its highest value in the age group of 95 years and above. Incidence trends for both men and women were similar to the overall trend, with slight differences. The overall prevalence also increases with age and is higher in women than men. There is an increasing trend in cardiovascular disease mortality after the age of 45, with males having a higher mortality rate than females at all ages. Compared with 1990, the rates of YLL, YLD and DALY in Chinese men increased by 36.99%, 102.42% and 40.78%, respectively, and increased by 2.79%, 107.13% and 11.50% in women in 2019. According to the data in 2019, the YLL rate, YLD rate and DALY rate of cardiovascular diseases in Chinese population showed an upward trend with the increase of age, with no inflection point. YLL rate and DALY rate of males gradually increased with the progress of population aging and were much higher than females, YLD rate gradually increased in the age group of 55-59 years and was much higher than males. From 1990 to 2019, the global standardized incidence, standardized prevalence and standardized mortality of cardiovascular diseases showed a downward trend by year, while the standardized morbidity and standardized mortality still increased in China, the standardized incidence and prevalence decreased, but that was still higher than the global scale. From the global level, the standardized YLL rate and DALY rate of cardiovascular diseases in China showed a downward trend along with the global level, but the disease burden of cardiovascular diseases in China was higher than the global level after 2000, and the standardized YLD rate increased by year. Risk factors associated with death from cardiovascular diseases mainly included smoking, second-hand smoke, alcohol consumption, low physical activity, high fasting blood glucose, high systolic blood pressure, high BMI, high low density lipoprotein cholesterol and renal insufficiency. From the relevant data in China and globally, high systolic blood pressure (hypertension) was still the primary risk factor for death from cardiovascular diseases, and the number of deaths was increasing by year. High density lipoprotein cholesterol (hyperlipidemia) was the second cause of death from cardiovascular diseases globally and in China in recent years. From 2020 to 2050, the standardized incidence of cardiovascular diseases in China is still on the rise, and it is expected that the standardized incidence of cardiovascular diseases will reach 663.618 per 100 000 by 2050. Conclusion The incidence, prevalence and mortality of cardiovascular diseases in China from 1990 to 2019 have shown an increasing trend by year. The disease burden caused by cardiovascular diseases is more severely, and there is no inflection point in the next 50 years. The prevalence and burden of diseases are higher than those of the world. It is expected that the standardized incidence of cardiovascular diseases will reach 663.618 per 100 000 by 2050.

Keywords